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Abstract 
Aim: To generate a putative patient based outcome measure specifically for 
Temporomandibular Disorders (TMDs) using a mixed-method approach. Methods: A 
combined quantitative-qualitative methodology was used to identify the most relevant 
items in the Oral Health Impact Profile (OHIP-49) for TMDs. The quantitative study 
involved 110 TMDs patients diagnosed using the Research Diagnostic Criteria for 
TMDs (RDC/TMD) and 110 age-sex matched controls. All subjects completed the 
OHIP-49. The qualitative study involved semi-structured interviews with a separate 
sample of TMDs patients (n=29). The two resultant data sets were analysed blinded 
and separately. Each data set used pre-determined rules to select candidate items 
for the putative OHIP for TMDs. The two sets of selected items were then compared 
using a priori rules to make a final item selection for OHIP TMDs. Results: Eighteen 
pre-existing items were selected through the quantitative process and fourteen by the 
qualitative process. On comparison of the two selections all but two of the items 
selected by the qualitative process had also been selected by the quantitative 
process. Two new candidate items emerged from the qualitative data that were not 
covered by OHIP-49. A twenty-two item putative OHIP-TMDs outcome measure 
emerged from the final selection process. Conclusion: A putative OHIP-TMDs 
outcome measure has been generated which requires further testing especially in 
relation to its responsiveness to change. 
Key words: Disability , OHIP, Oral health-related quality of life, Quality of life, 
Qualitative research, Temporomandibular Disorders, TMD. 
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Introduction 
 
Temporomandibular disorders (TMDs) are a group of complex 
biopsychosocial conditions. A number of systematic reviews of TMDs have 
highlighted the lack of evidence on which to base management decisions (1-
4). These reviews have suggested that one of the reasons for this paucity of 
evidence is the result of the lack of a standardised patient-based outcome 
measure, which would allow comparison of trial outcomes. These reviews 
along with a recent paper on disability assessment and oral rehabilitation 
have gone on to suggest quality of life (QOL) as an important outcome in 
treatment of TMDs (4-6). 
TMDs have been shown to impact on patients’ daily lives. Standard generic 
QOL measures may not be sensitive to some of these impacts (7-10). Most of 
the work demonstrating TMDs’ impact on QOL has used a common, generic 
oral health related QOL measure, the Oral Health Impact Profile (OHIP) (11, 
12). The specific impact of TMDs on components of the wider construct of 
QOL such as functional limitation have also been examined by stand alone 
instruments such as the jaw functional limitation scale amongst others (13, 
14). The wider group of chronic orofacial pain conditions have also been 
examined using the Manchester Orofacial Pain Disability Scale, but it is more 
specific to pain conditions and has excellent psychometric properties in this 
respect (15). 
Subjective measures constructed around QOL concepts are accepted as a 
method of measuring patient-centred outcomes (16-20). This is dependent on 
the proviso that the QOL measure in question is actually based on an 
examination of patient experiences (17, 18, 21, 22). Unchanged versions of 
OHIP have been used as an outcome measure for different conditions and 
diseases and been shown to be sensitive to change (23-29). OHIP has also 
be shown to be sensitive to change in TMDs (25), although this was with the 
full forty-nine item OHIP and several authors have suggested that in order to 
measure patient centred outcomes with QOL instruments a choice must be 
made between employing a generic, or a shorter (22, 26, 30-32) condition 
(disease) specific, instrument.  
A condition specific QOL measure will increase the sensitivity and 
discriminatory ability of the instrument and therefore is a better measure for 
those looking to detect small within subject change over time (21, 33, 34). 
This ability to detect change over time is paramount for any QOL measure 
being used as an outcome measure to determine the effects of treatment of a 
specific condition. 
Condition specific QOL measures can be constructed using one of two 
methods (22). The first of these methods is to create a wholly new construct 
and build a QOL measure based on the new construct. The disadvantages to 
this approach include: its time-consuming nature, its expense, and the 
questionable necessity to reinvent something that may already exist with 
current measures. 
The second method is to take a pre-existing measure that has established 
measurement properties and modify it. In simplified terms this can be 
accomplished by testing the existing measure with a disease-specific and 
control sample. A statistical approach can then be used to reduce the items 
down to a disease-specific subset. This process aims to maintain the 
precision of the instrument whilst increasing its utility through reducing 
respondent burden. 
The second method is the more attractive as a result of its ease, but it has its 
disadvantages. One of its major disadvantages stems from the fact that the 
resultant condition specific measure will only be based on the pre-existing 
items of the parent QOL measure and/or the, “expert” opinion of healthcare 
professionals. This can lead to two potential weaknesses. The first may occur 
due to floor effects; items with a low prevalence during testing may be 
rejected but may, however, have great importance to patients when they 
occur and therefore should not necessarily be rejected. The second potential 
weakness is that the pre-existing items may not fully encapsulate the effects 
of the condition the researcher wishes to investigate. The resultant condition-
specific measure may therefore lack sensitivity and construct validity (16, 35, 
36). 
Nevertheless, the second method for creating a condition-specific QOL 
measure is, however, the more attractive and pragmatic approach (37). The 
problems for those using this method are how: a) to ensure that the patient 
perspective is fully captured within the selection of pre-existent items for the 
disease specific subset; b) to ensure that no new items are required for the 
disease-specific QOL measure. This paper aims to use a pre-existing QOL 
measure, the Oral health Impact Profile, in order to create a putative patient 
based condition-specific outcome measure for TMDs (OHIP-TMDs) using a 
mixed method qualitative and quantitative approach.  
Materials and Methods 
 
The studies reported received approval from the local research ethics 
committee. A combined methodology in a quantitative-qualitative priority 
sequence model (38) was used and is graphically represented in Figure 1.  
Two separate and independent studies were used to collect the data: a 
quantitative study and a qualitative study. Both studies investigated OHIP-49 
which consists of 49 items (questions) distributed amongst seven domains: 
Functional limitation, Physical Pain, Psychological Discomfort, Physical 
Disability, Psychological Disability, Social Disability, Handicap. The item 
response is a five point Likert response: never, hardly ever, occasionally, fairly 
often, very often (scored 0-4).  
 
It is possible using the Likert scale response to score the OHIP by three 
methods all of which result in a score, with higher scores indicating poorer 
quality of life (23, 39). OHIP-additive is an ordinal score calculated by 
summing the response codes of all forty-nine responses (range 0-196) and 
was the method used in the quantitative part of this paper. 
 
Both reported studies aimed to select those items that were specific to 
patients with TMDs from the pre-existing forty-nine OHIP items. In the 
qualitative study there was an additional aim: to examine the qualitative data 
against the forty-nine OHIP items and identify any new items relevant to 
TMDs that were missing from the current forty-nine items. Both the 
quantitative and qualitative item selections were then brought together with 
their representative data and a set of predetermined rules were applied to the 
items each study had selected to achieve a final selection of items for the 
putative OHIP-TMDs outcome measure. 
 
Quantitative study methods 
 
The materials and methods used to collect the quantitative data in this paper 
have been described in detail elsewhere (40). Briefly, the quantitative study 
involved 110 consecutive new TMDs patients with 110 age-sex matched 
controls in six age bands (18-24; 25-34; 35-44; 45-54; 55-64; 65+). The 
patient group completed the slightly modified OHIP-49 questionnaire previous 
to any clinical intervention. The modifications made to OHIP were: 1) The 
reference period for each question was changed from one year to one month 
making the stem “Over the last month have you had….”; 2) The questions 
ending in, “because of problems with your teeth, mouth, or dentures” were 
modified to, “because of problems with your jaws, teeth, mouth, or dentures”. 
The reference period was changed on the basis of previous findings 
suggesting this was the optimum reference period for TMDs (41). The addition 
of “jaws” was to ensure that the patient understood that these questions also 
related to their TMD complaints. The patients also completed the 
Multidimensional Pain Inventory (42) and a 100mm visual analogue scale of 
their current pain to allow the convergent validity of OHIP to be assessed. 
 
The inclusion criteria were that the patient: was over eighteen years of age; 
had symptoms of TMDs for at least three months; had a Research Diagnostic 
Criteria diagnosis (43). The characteristics of the sample are shown in Table 
1. The control group had no history of TMDs and were selected from persons 
accompanying patients to appointments and non-clinical secondary care staff. 
The control group was age and sex matched to the patient group using six 
age bands.  
 
All quantitative data were crosschecked and then analysed with STATA 10 
(Stata/SE Statistical software: Release 10; Stata, College Station, TX, USA). 
OHIP was scored (23) and three main calculations were performed: individual 
items were tested for a significant difference between patient and control 
scores using a Mann Whitney test; item prevalence was calculated; item 
impact was calculated. Item prevalence was calculated by the percentage of 
individuals scoring “fairly or very often” (% FOVO) for the item. Item-impact 
was calculated by the method described by Allen & Locker (37) where the 
proportion of respondents (item prevalence) is multiplied by the severity score 
(the mean score) of the item.   
 
After calculation of item-specific statistics the final quantitative selection of 
items was achieved through a three-stage process. The overarching 
consideration for the process was the need to keep the domain structure of 
OHIP intact to ensure it remained true to its underlying construct (44). With 
this in mind the selection of items occurred in three stages: 
1) Any item that did not exhibit a significant difference (p>0.05 in Mann 
Whitney test) in score between patients and controls was rejected 
2) The item with the highest item-impact score difference between patient and 
control in each domain of OHIP was selected. This served to ensure that 
items selected were of importance to patients with TMDs 
3) Items with a clinically meaningful difference between patients’ and controls’ 
mean scores were also selected. This clinical meaningful difference was 
defined as greater than or equal to one unit as this means that the respondent 
group has moved from, for example, scoring an impact as “very often” to 
“fairly often”.  
 
Qualitative study methods 
 
Sample 
A purposive maximum variation sample was used; TMDs patients with likely 
differing experiences and symptoms were actively recruited from hospital 
consultation clinics, which resulted in a sample that captured a depth and 
breadth of patient illness experience (Table 2). All patients interviewed (n=29) 
were undergoing treatment for TMDs in a secondary care setting but were 
otherwise uninvolved in the quantitative study.  
Interviews 
Written informed consent was obtained before all interviews, which were 
conducted in a comfortable non-clinical office setting.. All interviews were 
digitally recorded, transcribed verbatim, and anonymised.  
Two trained interviewers carried out the semi-structured interviews. Both 
interviewers were blinded to the ongoing quantitative OHIP study. A broad, 
flexible, evolving topic guide constructed in line with the domains of Locker’s 
model of oral health (44) was used. A flexible approach to the use of the topic 
guide meant new ideas were explored naturally during the course of an 
interview.  
The qualitative data collection ended when no new themes or data relevant to 
OHIP items were being expressed (n=29).  
 
Data analysis 
 
An overview of the method of data analysis is shown in Figure 1. Initially this 
involved a framework analysis of the samples’ transcripts using the items of 
OHIP-49 as an a priori deductive framework (45). Line-by-line coding was 
used to analyse the transcripts for textual evidence that an OHIP item was of 
relevance to the interviewee. Data supporting an OHIP item was then placed 
into the coding framework. One researcher, blinded to the quantitative study’s 
results analysed the data (JD) and coded it into the OHIP items placing it into 
the appropriate column of the coding framework. A second blinded researcher 
(CE) then reviewed the coding and framework to ensure its validity. An 
example of the coding framework is shown in Figure 2. 
Any recurring emergent themes that did not fit the a priori framework were 
noted and analysed using an iterative and inductive method. Any recurring 
differences in phraseology for pre-existing items were also noted in this 
manner (face validity). One researcher (JD) then calculated the cumulative 
number of patients reporting impacts in each item. This was not for statistical 
purposes but to broadly illustrate the impacts patients were reporting.  
After the coding and insertion of the data into the framework, the coded data 
were examined to help guide a qualitative item selection process for a TMD-
specific subset of items from OHIP-49. The qualitative selection process had 
three stages: 
1) Rejection of any items where no qualitative data was found to support their 
inclusion  
2) Selection of an item if greater than fifty percent of the qualitative sample 
reported an impact relating to it. 
3) Selection of items where the context and manner by which the respondents 
reported the item indicated high levels of relevance to them: the researcher 
attempted to gauge the importance of the item to the patient by the manner in 
which it was reported. If it was apparent that the item was of great importance 
to those reporting impacts in relation to it then it was included irrespective of 
stage two. This was to try and avoid floor effects limiting the number of items 
included in the final set. 
 
Methods for final selection of items for OHIP-TMDs 
The qualitative data collection, analysis and selection process was 
independent and blinded to the quantitative results. Comparison of the final 
qualitative and quantitative item selections was only performed once both 
analyses were complete. This comparison of the two sets of selections 
allowed the final item selection to occur. The predetermined rules for the final 
selection of items for OHIP-TMDs were: 
1) All items selected by the quantitative study were considered the foundation 
of the measure and were preselected for OHIP-TMDs 
2) Additional items selected by the qualitative study were then examined 
against the quantitative selection and further pre-existent items suggested by 
the qualitative process were added. 
3) New recurrent themes from the qualitative study that were candidate items 
for OHIP-TMDs were then examined against the data supporting them and 
pre-existing OHIP items. If the theme was strongly supported by the data, 
concurrent with the clinical experience of the authors, and not covered in any 
manner by a pre-existing item, it was converted to an item using the 
phraseology of those that reported it. 
Once the final selection of items was complete for OHIP-TMDs a secondary 
analysis was performed to provisionally examine the properties of the putative 
set of items against items comprising OHIP-14, and OHIP-49. Items 
comprising each of the versions of OHIP 14 and OHIP-TMDs were extracted 
from the responses to OHIP 49 and calculations were performed using the 
extracted items. An unpaired t-test was used to examine the difference 
between patients and controls’ summary scores for OHIP TMDs, OHIP 14, 
and OHIP 49. The Cronbach’s alpha for all three versions was calculated and 
all three versions’ degree of convergent validity with the impairment scale of 
the MPI and VAS of the patient’s current pain was calculated using a 
Spearman’s Rho. Floor effects of all three versions of OHIP were investigated 
using the number of questions answered as zero (never) (32). The 
percentage of patients achieving a summary OHIP-ADD score of zero was 
calculated, and the number of items per patient scored as zero was 
calculated, followed by the mean number of items scored as zero per 
instrument.
Results 
 
Quantitatively selected items 
In stage one of the quantitative selection process both control and patients’ 
item scores were examined to determine if there was a significant difference 
between them: eight items had no significant difference (p>0.05) and were 
rejected (Items 3, 7, 9, 18, 26, 30, 31, 45).  
After stage one the differences between the patients and controls were 
calculated for mean score and item-impact for all the remaining items. 
Applying the remaining two stages of the item selection process to those 
items remaining after stage one a subset of 18 items were identified (Table 3). 
 
Qualitative results 
 
There were fourteen items within the qualitative framework without supporting 
data and these were rejected (Items 3, 5, 6, 7, 8, 9, 15, 18, 23, 26, 27, 30, 31, 
32).  
The qualitative selection process resulted in fourteen items being selected. Of 
those fourteen items, seven were chosen due to their cumulative frequency 
and/or importance (Items 1, 10, 11, 16, 19, 28, 33), and seven items were 
chosen on the basis of their apparent importance to the patient alone (Items 
12, 20, 21, 36, 42, 43, 49) according to the a priori rules. Table 4 shows those 
items selected with representative quotes. The cumulative frequencies for 
every OHIP item with data are available in the online appendix 
(http://XXXXXXXX).  
Recurrent new themes 
Four recurrent themes emerged from the data that were not examined by pre-
existing OHIP items. These four themes were: difficulties with mouth opening 
(n=11); painful speech (n=7); clicking (n=18); and misalignment of teeth (n=4). 
 
Difficulties with mouth opening were expressed in terms of lack of opening 
(example: Pt 18 below) and less commonly as an inability to close fully 
(example: Pt 26 below); both were described in terms of a functional limitation 
that could cause psychological discomfort and social disability. Pre-existing 
OHIP items covered the types of psychological and social disability 
expressed, but no pre-existing items covered the functional limitation 
described. 
 
“I do get quite distressed when I have to have [dental] 
impressions taken or when people say “oh open it wider” and I 
say “I simply can’t”.  Some people think I’m actually being, you 
know, obstructive.  I’m not, I simply cannot open my mouth 
very wide, and if I do it will hurt terribly and then click and 
sometimes lock.  And that’s quite frightening” (Pt 18)  
 
Patients often recounted their TMD causing a great deal of pain when 
speaking, especially if for long periods of time. This TMDs-specific type of 
pain was not covered within the physical pain domain of OHIP. 
 
“I had it during the day as well because I worked as a 
Receptionist and I found that if I’d been talking a long time, 
speaking a long time on the telephone it was really painful 
by the end of the evening, it was really sore.  And I couldn’t 
stand anyone else to touch the side of my face” (Pt 18) 
 
“Just, as I say, when I spoke.  Just speaking seemed to 
make everything sore and achy” (Pt 13) 
 
Complaints about clicking on opening recurred throughout the data set but not 
all those complaining of clicking reached a RDC/TMD group II diagnosis (43). 
Clicking per se is not examined specifically by OHIP. Clicking as a complaint, 
however, seemed to have few impacts on quality of life that were not already 
captured by pre-existing OHIP items (Items 19 & 20). It seemed to cause the 
psychological discomfort of worry and self-consciousness. Clicking’s effect on 
QOL was therefore recorded against items 19 and 20 and its apparent 
importance was also noted (Table 4). 
 
“Yeah, very conscious of it, certainly.  It would make 
people turn round and say what on earth is that, 
because it was just so loud.  And be on the left side.  It 
was like a bullet going off” (Pt 27) 
 
Individuals also mentioned the arrangement of their teeth as a functional 
limitation. The functional limitation of a feeling of misalignment of teeth was a 
recurring theme. It was, however, the least frequent new theme not covered 
by OHIP-49, appeared not to have a large impact, and may have been 
brought about by specific treatment the individuals in question had received. It 
was therefore not selected for inclusion in the putative OHIP-TMDs outcome 
measure. 
 
Final selection of items for TMD specific OHIP outcome measure  
 
Table 5 shows all items selected for a TMD specific subset with the rationale 
for selection. A total of twenty pre-existing items were selected from OHIP-49, 
of these: twelve were selected by both the quantitative and qualitative 
selection processes; six were selected on the basis of quantitative selection 
process alone; two were selected on the basis of qualitative selection process 
alone.   
Out of the four new recurring themes from the qualitative study, two, 
difficulties with mouth opening, and painful speech, were selected and 
phrased into new items. Table 5 shows the putative twenty-two item final 
outcome measure (OHIP-TMDs). Provisional testing of some of the 
psychometric properties of the OHIP-TMDs outcome measure without the two 
new items is shown in table 6 against the performance of OHIP 14 and OHIP 
49. No version of OHIP exhibited a summary score of zero, but the three 
versions had varying mean numbers of items scored as zero (Table 6). 
Discussion 
In chronic conditions such as TMDs, where a cure is unlikely, management 
must be patient-centred to help reduce the effects of the illness. Subjective 
health measures, particularly those built around a robust theoretical structure, 
incorporate patient perspectives, but there is always concern over the 
specificity of their items to a particular condition or disease.  
 
The reduction of a measure to its condition-specific items is especially 
desirable if the intention is to use it to measure change in that condition. 
Without reduction statistical “noise” from the non-specific items will limit the 
measure’s responsiveness to change, but the measure must also fully 
encapsulate the impacts of the condition on the individual. QOL measures 
such as OHIP can be reduced in size to a more condition specific subset 
using various statistical methods (37, 46, 47). Previously there has been no 
attempt in this reduction process to incorporate the qualitative patient 
experiences of the specific condition, which might help with the item 
reduction/selection process. Purely statistical methods used to shorten and 
refine measures to more condition specific measures have been shown to 
produce measures that can suffer from floor effects (32), and that may lack 
specificity and validity from the patient perspective (17) especially if factor 
analysis alone is used (48). These limitations will largely be due to the fact 
that researchers have not gone back to a condition-specific purposive sample 
of patients to ensure that their experiences are adequately represented in the 
measure.  
 
This study attempted to increase the specificity of the item reduction of OHIP-
49 to a condition-specific patient based outcome measure for TMDs by using 
two main methods to select items thus trying to minimise the disadvantages of 
either method. Without testing the psychometric properties of the putative 
subset of OHIP items (OHIP-TMDs) with new cohorts in a range of 
cultures/countries we cannot claim this as a definitive measure, but what is 
apparent from our results is that there are benefits to be gained from adopting 
our “dual reduction” approach. These benefits include limiting the floor effects 
and reducing concerns about missing items/content in a purely quantitative 
approach (content validity), especially in the higher impact domains where 
analysis of item scores and therefore selection of items can be by very small 
numerical margins.  
 
Specific advantages of the additional qualitative selection process were 
related to the selection of items of apparent importance to patients. The 
qualitative selection process helped to confirm and validate the quantitative 
selection and limited the potential of an item-impact method to produce a 
group-centred as opposed to a patient centred questionnaire (36). It also 
helped the selection of items in the higher impact domains. This was 
especially important in employing the a priori quantitative selection rules as 
only one item was selected in each of the handicap and social disability 
domains. Without the qualitative selection process identifying one further 
additional item in each of these domains the domain representation in the final 
score, and the stability of the measure, might have been adversely affected 
(49). The provision of a new item from the qualitative data in the functional 
limitation domain in addition to the singular item selected by the quantitative 
process also helped ensure representation and stability (50, 51). The two new 
items suggested for inclusion are further supported by other research that 
found these two activities to be in the top five daily activities reported by a 
patient-specific approach as limited by TMD (52). 
 
The qualitative selection process used here involved multiple parties and 
researchers and is supported by narrative data. As such it is arguably more 
robust than, for example, a pure Delphi-type process expert selection, which 
has been used in the reduction of measures in the past (53, 54). Cross-
cultural differences and linguistic interpretation may account for some of the 
differences between our results and those of two previous studies using OHIP 
with TMDs, but some of those differences could prove to be critical. For 
instance the elimination of “felt self-conscious” (Item 20) (54), or of an entire 
domain on physical pain (53) would, on the evidence that OHIP responses 
change with item-order (51) and on the basis of our results, greatly affect the 
measure’s properties because these were some of the highest, and most 
frequently, scored items in our results. This highlights the necessity to go back 
to the population being studied to ensure that decisions made are valid and 
representative of patient experiences (36).  
 
When reducing QOL measures down to smaller condition-specific subsets 
using any method there are particular limitations that may become apparent in 
the resultant measure. These include effects on discriminatory ability, 
responsiveness to change, construct validity, and reliability. The final subset 
outlined by this paper therefore requires further testing with appropriate 
samples to help ascertain its properties with respect to this. We have, 
however, sought to limit some of these effects by: adopting the item-impact 
method suggested by Allen and Locker for creating shortened measures 
responsive to change (32); attempting to include at least two items from each 
domain to help reduce anomalous responses from patients (50); keeping the 
original order and domain structure of the measure intact as far as possible to 
maintain its psychometric properties and reduce the order effect (51). We are 
therefore confident that it should perform well as an outcome measure. The 
preliminary testing of OHIP-TMDs albeit using analysis on extracted items 
from OHIP-49 would suggest that it has: comparable internal reliability to 
OHIP-49, may be less susceptible to floor effects than OHIP-49, and appears 
to have better convergent validity with pain and pain-related disability 
measures than OHIP-14 and 49. 
 
The disadvantages to the method reported are that it is labour and time 
intensive due to its dual approach. Nevertheless we believe that it is still more 
pragmatic than creating a new outcome measure. The decision remains 
whether or not the final subset of selected items would function as a “stand-
alone” outcome measure for TMDs (a twenty-two item OHIP-TMDs), or 
whether OHIP 49 with two additional items inserted should be employed and 
a subset analysis conducted. This decision can only be made on the basis of 
further testing of OHIP-TMDs against OHIP 49 with specific emphasis on the 
two instruments’ responsiveness to change. This study has highlighted, 
however, the items of greatest relevance to patients with TMDs and two 
further items that need to be considered for inclusion when using OHIP with 
patients suffering from TMDs. The other final disadvantage of the creation of 
an OHIP-TMDs is that some researchers may employ it in preference to 
OHIP-49, or OHIP-14 for examining QOL in epidemiological surveys of TMDs, 
which will result in loss of the comparability of results across orofacial 
conditions. The authors would reiterate that OHIP-TMDs is intended to be a 
patient based condition-specific outcome measure for TMDs and not for 
epidemiological surveys. It might be pertinent, however, for such 
epidemiological surveys to include the additional two items if they intend to 
incorporate TMDs in their survey. 
Conclusion 
 
This study shows that it is possible to combine the “standard” quantitative 
statistical approaches to creating a condition-specific patient based outcome 
measure with qualitative data on patient experiences of the condition. This 
helps to reduce the number of items to those with the capacity to change, to 
eliminate the risks of floor effects for entirely statistically driven approaches, 
and to ensure content validity for the patient group. The study proposes a 
putative outcome measure for TMDs, which requires further testing to 
examine its psychometric properties.  
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Tables 
 
Table 1 Distribution of 110 patients within different RDC/TMD diagnostic 
groups* for Quantitative study 
Group I Group II Group III 
Myofascial pain Disc Displacements Arthritides 
Without limited opening  52% With reduction 41% Arthralgia 36% 
With limited opening  15% Without reduction 7% Osteoarthritis 5% 
  Osteoarthrosis 3% 
   Percentage of  
patients with 
One Diagnosis Two Diagnoses Three Diagnoses 
52% 36% 12% 
* Patients could have more than one TMJ related diagnosis within Groups II 
and III. Within Group I only a single diagnosis was possible, but with multiple 
diagnoses possible between groups. 
 Table 2 Characteristics of qualitative purposive sample  
Patient number  
 
Gender Age Diagnosis* 
1 Female 65 MFPA, DD 
2 Female 35 MFPA 
3 Female 59 MFPA 
4 Female 37 DD, MFPA 
5 Female 52 MFPA 
6 Female 54 MFPA, DD  
7 Female 34 DD 
8 Female 47 MFPA 
9 Female 33 MFPA 
10 Male 38 MFPA 
11 Male 33 MFPA, DD 
12 Female 18 MFPA, DD 
13 Female 48 MFPA 
14 Male 48 MFPA 
15 Female 26 MFPA  
16 Female 36 MFPA 
17 Female 60 MFPA 
18 Female 47 MFPA 
19 Female 38 MFPA 
20 Female 23 MFPA, DD 
21 Male 58 DD 
22 Female 57 MFPA 
23 Female 52 MFPA 
24 Female 41 DD 
25 Female 46 MFPA 
26 Female 47 DD 
27 Female 24 DD 
28 Male 42 MFPA 
29 Male 33 DD, MFPA 
All patients had >three months in treatment 
* Diagnosis made by criteria derived from the research diagnostic criteria (43) and simplified 
into two groups: 1) Myofascial and arthritides (MFPA); 2) Disc displacements (DD) 
  
 
 
Table 3 - Final quantitative selection of items after the three-stage item 
selection process. 
Domain 
Ite
m
 N
o
. 
Summary of item 
D
iffe
re
n
c
e
  in
 M
e
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n
 
D
iffe
re
n
c
e
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 Ite
m
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t 
R
a
tio
n
a
le
 fo
r 
in
c
lu
s
io
n
* 
Functional limitation 1 Chewing any foods 2.12 120.4 HI 
Physical Pain 10 Painful aching in your mouth 1.90 133.9 M 
11 Had a sore jaw 2.70 205.2 HI 
12 Had headaches  1.78 87.1 M 
16 Uncomfortable to eat any foods  1.87 113.7 M 
Psychological discomfort 
 
19 Worried by dental problems 2.08 132.6 HI 
20 Self-conscious  1.00 43.0 M 
21 Dental problems made you miserable 1.65 75.7 M 
23 Felt tense because of problems  1.72 65.7 M 
Physical disability 28 Had to avoid eating some foods  1.93 93.0 HI 
32 Interrupt meals  1.29 35.2 M 
Psychological disability 33 Sleep been interrupted  1.52 59.0 HI 
34 Been upset  1.46 44.6 M 
35 Difficult to relax  1.57 54.7 M 
36 Felt depressed  1.10 19.5 M 
37 Concentration been affected  1.37 33.7 M 
Social disability 42 Been a bit irritable with other people  0.99 14.5 HI 
Handicap 47 Life in general less satisfying  0.94 12.3 HI 
* HI – Highest item-impact in the respective domain; M – Mean score difference 
Table 4 - Qualitative selection of items 
Domain 
Ite
m
 N
o
. 
Summary of item 
F
re
q
u
e
n
c
y
 o
f 
Q
u
a
lita
tiv
e
 re
p
o
rts
 
(n
=
2
9
) 
Representative quotation from data 
Functional 
limitation 
  1 
Chewing any 
foods 
20 
“Different kinds of food.  If I was eating toffee, well I couldn’t eat toffee.  
Couldn’t eat Hamburger because I couldn’t get my mouth open that wide.  
Like hard food, like chewy food” (Pt 27) 
Physical Pain 
10 
Painful aching in 
your mouth 21 
“When I had my six monthly [dental] check-up and my cheeks were sore” (Pt 
6) 
11 Had a sore jaw 21 “I had discomfort in my jaw” (Pt 1) 
12 
Had headaches  
13* 
“Headaches, a lot of bad heads.  Just constantly crying in pain all the time, 
very depressed” (Pt 2) 
16 
Uncomfortable to 
eat any foods  
19 
“I mean certain things I always liked and I avoid because that made it worse.  
Like I love crusty buns and I just avoid anything where I’ve got to chew too 
much, you know.  Because I keep thinking there’s no point in putting yourself 
in pain, you know.  So some of the things I have cut out to save like the pain, 
you know” (Pt 7) 
Psychological 
discomfort 
 
19 
Worried by 
dental problems 20 
“I was worried about it [the pain] because I was getting shooting pain right up 
there, right up the side” (Pt 14) 
20 
Self-conscious  
4* 
“Yeah, very conscious of it [the click], certainly.  It would make people turn 
round and say what on earth is that, because it was just so loud.  And be on 
the left side.  It was like a bullet going off” (Pt 26) 
21 
Dental problems 
made you 
miserable 9* 
“I just wanted to lie in bed all the time I was in just so much pain, I didn’t want 
to get out of bed…..just crying all the time.  And back to the dentist and the 
hospital and everything, it was awful” (Pt 2) 
Physical 
disability 
28 
Had to avoid 
eating some 
foods  
15 
“I couldn’t … the volume of food I couldn’t pile up my fork and stuff it in so I 
was eating slower and I think I stopped eating as much really just because I 
was eating slower.  And then I stopped eating certain foods.  So I’d maybe 
just eat pasta rather than say if I had a roast dinner then roast potatoes would 
have to be mashed down and things like that” (Pt 15) 
Psychological 
disability 
33 
Sleep been 
interrupted  
17 
“I wasn’t sleeping at night properly and therefore I was tired when I went to 
work and then I was probably getting more stressed and my tolerance level 
was probably lower” (Pt 16) 
36 
Felt depressed  
11* 
“When the pain is to the degree which mine has been, I’ve never been down 
or a depressive person in any form, but since that is the type of pain where, 
and discomfort, where it’s impossible not to get down about” (Pt 9) 
Social 
disability 
42 
Been a bit 
irritable with 
other people  
8* 
“Because of the mood swings [due to the pain].  The mood swings and just 
that I couldn’t cope with my husband winding us up, my son winding me up, 
you know.  Running your home, you know, doing your housewifely things, 
trying to do a full-time job, you know, and it’s a lot” (Pt 23) 
43 
Difficulty doing 
your usual jobs  
8* 
"I feel as though I’ve got very little energy, I could do very little in the house.  I 
mean my husband, who’s a lot older than I am, and he does everything for 
me." (Pt 22) 
Handicap 
 
49 
Unable to work 
to your full 
capacity  8* 
“I was doing a very demanding job at the time and I gave that up [because of 
the pain]" (Pt 18) 
* Chosen on basis of importance 
Table 5 - Final selection of items for TMD specific sub-set 
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Functional 
limitation 
  
1 Chewing any foods 2.12 120.4 20 X X 
Add 
Have you had difficulties in opening and 
closing your mouth? NA NA 11 
 X 
Physical Pain 10 Painful aching in your mouth 1.90 133.9 21 X X 
11 Had a sore jaw 2.70 205.2 21 X X 
12 Had headaches  1.78 87.1 13 X X 
16 Uncomfortable to eat any foods  1.87 113.7 19 X X 
Add 
Have you felt speech was painful because 
of problems with your teeth, mouth, 
dentures or jaws? NA NA 7 
 X 
Psychological 
discomfort 
 
19 Worried by dental problems 2.08 132.6 20 X X 
20 Self-conscious  1.00 43.0 4 X X 
21 Dental problems made you miserable 1.65 75.7 9 X X 
23 
Felt tense because of problems  
1.72 65.7 0 X 
 
Physical 
disability 
28 Had to avoid eating some foods  1.93 93.0 15 X X 
32 
Interrupt meals  
1.29 35.2 0 X 
 
Psychological 
disability 
33 Sleep been interrupted  1.52 59.0 17 X X 
34 
Been upset  
1.46 44.6 6 X 
 
35 
Difficult to relax  
1.57 54.7 4 X 
 
36 Felt depressed  1.10 19.5 11 X X 
37 
Concentration been affected  
1.37 33.7 2 X 
 
Social disability 42  Been a bit irritable with other people  0.99 14.5 8 X X 
43 Difficulty doing your usual jobs  0.61 8.8 8  X 
Handicap 
 
47  Life in general less satisfying  0.94 12.3 5 X  
49 Unable to work to your full capacity  0.68 7.9 8  X 
 
 Table 6 – Provisional testing of OHIP-TMDs without the two new items 
Measure Cronbach’s 
alpha of 
instrument  
Unpaired T-
test 
summary 
score of 
instrument  
patient vs 
controls 
Convergent validity of 
instrument (summary 
score)  
Spearman’s Rho 
correlation coefficient 
Mean number 
of items 
across the 
patient sample 
answered as 
zero (never). 
[S.D.] 
 
MPI VAS of 
current 
pain 
OHIP 49 0.951 P<0.01 
CI (36.66, 
50.34) 
0.738** 0.528** 23 [10] 
OHIP 14 0.890 P<0.01 
CI (12.45, 
16.93) 
0.719** 0.524** 6 [3] 
OHIP 
TMDs 
(20 pre-
existing 
items 
selected) 
0.942 P<0.01 
CI(26.57, 
33.93) 
0.751** 0.576** 5 [4] 
** p<0.01 (two-tailed) 
 
 
Web Appendix 
 
 
 
 
Table - Items with qualitative data to support them 
 
Domain 
Ite
m
 N
o
. 
Summary of item 
F
re
q
u
e
n
c
y
 o
f 
Q
u
a
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tiv
e
 re
p
o
rts
 
(n
=
2
9
) 
Functional limitation 
  
1 Chewing any foods 20 
2 Pronouncing any words  1 
4 Appearance has been affected  3 
Physical Pain 10 Painful aching in your mouth 21 
11 Had a sore jaw 21 
12 Had headaches  13 
13 Had sensitive teeth 1 
14 Had toothache 10 
16 Uncomfortable to eat any foods  19 
17 Sore spots in your mouth 1 
Psychological discomfort 
 
19 Worried by dental problems 20 
20 Self-conscious  4 
21 Dental problems made you miserable 9 
22 Uncomfortable about the appearance  1 
Physical disability 24 Has your speech been unclear  3 
25 People misunderstood some of your words  1 
28 Had to avoid eating some foods  15 
29 Diet been unsatisfactory  1 
Psychological disability 33 Sleep been interrupted  17 
34 Been upset  6 
35 Difficult to relax  4 
36 Felt depressed  11 
37 Concentration been affected  2 
38 Been embarrassed  1 
Social disability 39 Avoided going out  2 
40 Less tolerant of your spouse or family  6 
41 Trouble getting on with other people  2 
42 Been a bit irritable with other people  8 
43 Difficulty doing your usual jobs  8 
Handicap 
 
44 Your general health has worsened  2 
45 Suffered any financial loss  2 
46 Unable to enjoy other peoples company as much  4 
47 Life in general less satisfying  5 
48 Totally unable to function  3 
49 Unable to work to your full capacity  8 
 
  
 
